Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma.
Fukano R, Mori T, Fujita N, Kobayashi R, Mitsui T, Kato K, Suzuki R, Suzumiya J, Fukuda T, Shindo M, Maseki N, Shimoyama T, Okada K, Inoue M, Inagaki J, Hashii Y, Sato A, Tabuchi K.
Fukano R, et al. Among authors: maseki n.
Int J Hematol. 2019 Dec;110(6):723-728. doi: 10.1007/s12185-019-02748-1. Epub 2019 Oct 16.
Int J Hematol. 2019.
PMID: 31620968